# Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors

> **NCT00005955** · PHASE2 · COMPLETED · sponsor: **Duke University**

## Conditions studied

- Brain and Central Nervous System Tumors
- Neuroblastoma

## Interventions

- **DRUG:** temozolomide

## Key facts

- **NCT ID:** NCT00005955
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-08
- **Primary completion:** —
- **Final completion:** 2002-09
- **Target enrollment:** — (—)
- **Last updated:** 2013-06-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005955, "Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00005955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*